GGrantIndex
← Leaderboards

Mark Joseph Mulligan

New York University School Of Medicine

$87,307,980
Attributed
$95,132,405
Total exposure
13
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $15.8M · FY200825
$20M$15M$10M$5M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$95,132,405 · 13

By mechanism

N01$37,955,723 · 3
UM1$34,136,693 · 2
U19$15,724,588 · 6
U01$4,831,287 · 1
T32$2,484,114 · 1

Top collaborators

Most similar at New York University School Of Medicine

Same institution · by research overlap

Others in their field

Top investigators on “Vaccines

Research focus

VaccinesDesignResourcesEvaluationConduct Clinical TrialsContractsNamed GroupCommunicable DiseasesClinical TrialsInvestigationRouteInfectious Disease TreatmentClinical ResearchProgramsCombatEnrollmentUniversitiesVaccinationReportingClinicAdultResponseCommunitiesVaccine Candidate

Grant awards (132)

Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)$249,587
UM1 · FY2025 · AI · contact PI
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)$46,709
UM1 · FY2025 · AI · contact PI
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)$804,593
UM1 · FY2024 · AI · contact PI
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)$631,871
UM1 · FY2023 · AI · contact PI
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)$638,651
UM1 · FY2022 · AI · contact PI
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)$543,651
UM1 · FY2022 · AI · contact PI
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)$375,787
UM1 · FY2022 · AI · contact PI
Vaccine and Treatment Evaluation Units: Overall Administration, Clinical Operations Support, Protocol Development$106,523
N01 · FY2022 · AI · contact PI
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)$6,820,430
UM1 · FY2021 · AI · contact PI
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU) - DMID 21-0012$1,341,481
UM1 · FY2021 · AI · contact PI
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)$655,601
UM1 · FY2021 · AI · contact PI
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU) – DMID 21-0004$625,430
UM1 · FY2021 · AI · contact PI
Core B: System Biological Analyses of Innate and Adpative Responses to Vaccination$466,445
U19 · FY2021 · AI · contact PI
Vaccine and Treatment Evaluation Units: Overall Administration, Clinical Operations Support, Protocol Development$106,272
N01 · FY2021 · AI · contact PI
Vaccine and Treatment Evaluation Unit: Phase I Clinical Trial to Evaluate a Hepatitis E Vaccine$2,714
N01 · FY2021 · AI · contact PI
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)$9,214,781
UM1 · FY2020 · AI · contact PI
Core B: System Biological Analyses of Innate and Adpative Responses to Vaccination$5,125,237
U19 · FY2020 · AI · contact PI
Vaccine and Treatment Evaluation Units: Noninferiority Trial to Inform Treatment of Lower Respiratory Tract Infections (LRTI)$455,564
N01 · FY2020 · AI · contact PI
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)$451,484
UM1 · FY2020 · AI · contact PI
Core B: System Biological Analyses of Innate and Adpative Responses to Vaccination$400,815
U19 · FY2020 · AI · contact PI
Vaccine and Treatment Evaluation Units: Overall Administration, Clinical Operations Support, Protocol Development, Implementation and Assays.$190,742
N01 · FY2020 · AI · contact PI
VTEU PHASE 2 EBOLA VIRUS VACCINE TRIAL$1,197,070
N01 · FY2019 · AI · contact PI
Vaccine and Treatment Evaluation Units: Noninferiority Trial to Inform Treatment of Lower Respiratory Tract Infections (LRTI)$1,127,342
N01 · FY2019 · AI · contact PI
Vaccine and Treatment Evaluation Units: Overall Administration, Clinical Operations Support and Concept and Protocol Development, Implementation and Assays for a Phase I Rabies Virus Vaccine Trial$721,834
N01 · FY2019 · AI · contact PI
Vaccine and Treatment Evaluation Unit: Phase I Clinical Trial to Evaluate a Hepatitis E Vaccine$599,552
N01 · FY2019 · AI · contact PI
Vaccine and Treatment Evaluation Units: Protocol Development and Implementation for a Phase I Trial for Influenza Vaccine$588,893
N01 · FY2019 · AI · contact PI
Vaccine and Treatment Evaluation Units: Overall Administration, Clinical Operations Support, Protocol Development, Implementation and Assays.$480,372
N01 · FY2019 · AI · contact PI
Core B: System Biological Analyses of Innate and Adpative Responses to Vaccination$278,619
U19 · FY2019 · AI · contact PI
Vaccine and Treatment Evaluation Units: Protocol Development and Implementation for a Natural History Challenge Study for Influenza$39,972
N01 · FY2019 · AI · contact PI
Vaccine and Treatment Evaluation Units: Protocol Development for a Phase III Dengue Vaccine Study$16,178
N01 · FY2019 · AI · contact PI
Emory- Duke- Orlando- CDC (EmDOC) Clinical Trials Unit$2,783,692
UM1 · FY2018 · AI
VACCINE AND TREATMENT EVALUATION UNITS: PHASE IV TRIAL TO EVALUATE THERAPEUTICS FOR RESISTANT BACTERIAL INFECTIONS$1,343,689
N01 · FY2018 · AI · contact PI
VTEU: Noninferiority Trial to Inform Treatment of Lower Respiratory Tract Infections (LRTI)$998,309
N01 · FY2018 · AI · contact PI
Vaccine and Treatment Evaluation Unit: Assay Work for Yellow Fever Vaccines$963,202
N01 · FY2018 · AI · contact PI
Core B: System Biological Analyses of Innate and Adpative Responses to Vaccination$887,141
U19 · FY2018 · AI · contact PI
VTEU PHASE I EBOLA VIRUS VACCINE TRIAL$536,787
N01 · FY2018 · AI · contact PI
VTEU PHASE 2 EBOLA VIRUS VACCINE TRIAL$508,405
N01 · FY2018 · AI · contact PI
Vaccine and Treatment Evaluation Unit - Clinical Operations Support$507,791
N01 · FY2018 · AI · contact PI
VACCINE TREATMENT AND EVALUATION UNIT: PHASE I NOROVIRUS VACCINE TRIAL$412,054
N01 · FY2018 · AI · contact PI
Vaccine and Treatment Evaluation Unit: Assay Work for Diagnostics Development for Bacterial Pathogens$391,942
N01 · FY2018 · AI · contact PI
Clinical and Statistical$360,480
U19 · FY2018 · AI · contact PI
Vaccine and Treatment Evaluation Units: Phase II Clinical Trial to Evaluate an Influenza Vaccine$343,923
N01 · FY2018 · AI · contact PI
VACCINE TREATMENT AND EVALUATION UNIT$187,925
N01 · FY2018 · AI · contact PI
Vaccine and Treatment Evaluation Units: Phase I Clinical Trial to Evaluate a Yellow Fever Virus Vaccine$186,478
N01 · FY2018 · AI · contact PI
VACCINE TREATMENT AND EVALUATION UNIT: CLINICAL OPERATIONS SUPPORT$79,065
N01 · FY2018 · AI · contact PI
Vaccine and Treatment Evaluation Unit: Phase I Clinical Trial to Evaluate a Hepatitis E Vaccine$77,430
N01 · FY2018 · AI · contact PI
Vaccine and Treatment Evaluation Unit: Phase I Clinical Trial to Evaluate a Tuberculosis Vaccine$50,104
N01 · FY2018 · AI · contact PI
Training a new generation of vaccinologists$12,309
T32 · FY2018 · AI · contact PI
Emory- Duke- Orlando- CDC (EmDOC) Clinical Trials Unit$2,403,962
UM1 · FY2017 · AI
Vaccine and Treatment Evaluation Unit: Assay Work for Yellow Fever Vaccines$1,360,130
N01 · FY2017 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNITS: PHASE IV TRIAL TO EVALUATE THERAPEUTICS FOR RESISTANT BACTERIAL INFECTIONS$1,282,074
N01 · FY2017 · AI · contact PI
VACCINE TREATMENT AND EVALUATION UNIT: PHASE I NOROVIRUS VACCINE TRIAL$611,678
N01 · FY2017 · AI · contact PI
VTEU: Noninferiority Trial to Inform Treatment of Lower Respiratory Tract Infections (LRTI)$520,509
N01 · FY2017 · AI · contact PI
Clinical and Statistical$490,903
U19 · FY2017 · AI · contact PI
Core B: System Biological Analyses of Innate and Adpative Responses to Vaccination$472,599
U19 · FY2017 · AI · contact PI
VACCINE TREATMENT AND EVALUATION UNIT: CLINICAL OPERATIONS SUPPORT$369,743
N01 · FY2017 · AI · contact PI
VACCINE AND EVALUTION TREATMENT UNITS:PHASE I CLINICAL TRIAL OF A NOROVIRUS VACCINE CANDIDATE$194,950
N01 · FY2017 · AI · contact PI
Training a new generation of vaccinologists$169,987
T32 · FY2017 · AI · contact PI
VACCINE TREATMENT AND EVALUATION UNIT: CONCEPT AND PROTOCOL DEVELOPMENT$79,065
N01 · FY2017 · AI · contact PI
VACCINE AND EVALUTION TREATMENT UNITS:PHASE I CLINICAL TRIAL OF A HPV VACCINE CANDIDATE$3,039
N01 · FY2017 · AI · contact PI
Training a new generation of vaccinologists$2,325
T32 · FY2017 · AI · contact PI
Emory- Duke- Orlando- CDC (EmDOC) Clinical Trials Unit$2,052,913
UM1 · FY2016 · AI
VTEU: Natural History Study of Zika Virus$1,729,319
N01 · FY2016 · AI · contact PI
Core B: System Biological Analyses of Innate and Adpative Responses to Vaccination$501,380
U19 · FY2016 · AI · contact PI
Clinical and Statistical$327,125
U19 · FY2016 · AI · contact PI
Training a new generation of vaccinologists$282,090
T32 · FY2016 · AI · contact PI
Training a new generation of vaccinologists$74,621
T32 · FY2016 · AI · contact PI
VTEU: Noninferiority Trial to Inform Treatment of Lower Respiratory Tract Infections (LRTI)$67,811
N01 · FY2016 · AI · contact PI
VTEU: Assay Work for Yellow Fever Vaccines$38,524
N01 · FY2016 · AI · contact PI
Emory- Duke- Orlando- CDC (EmDOC) Clinical Trials Unit$1,977,185
UM1 · FY2015 · AI
Assay Work for Yellow Fever Vaccines - VTEU$1,213,064
N01 · FY2015 · AI · contact PI
Phase I Trial of Yellow Fever Virus Vaccines - VTEU$683,453
N01 · FY2015 · AI · contact PI
VACCINE AND EVALUTION TREATMENT UNITS$649,581
N01 · FY2015 · AI · contact PI
Core B: System Biological Analyses of Innate and Adpative Responses to Vaccination$436,264
U19 · FY2015 · AI · contact PI
Clinical and Statistical$331,235
U19 · FY2015 · AI · contact PI
Vaccine and Treatment Evaluation Unit$277,215
N01 · FY2015 · AI · contact PI
Training a new generation of vaccinologists$273,442
T32 · FY2015 · AI · contact PI
Training a new generation of vaccinologists$70,087
T32 · FY2015 · AI · contact PI
Emory- Duke- Orlando- CDC (EmDOC) Clinical Trials Unit$2,518,885
UM1 · FY2014 · AI
Phase I Trial to Evaluate Cytomegalovirus Therapeutics - VTEU$944,454
N01 · FY2014 · AI · contact PI
Clinical and Statistical$662,585
U19 · FY2014 · AI · contact PI
Clinical and Statistical$469,853
U19 · FY2014 · AI · contact PI
Phase IIb Pneumococcal Conjugate Vaccine Trial - VTEU$356,164
N01 · FY2014 · AI · contact PI
Vaccine and Treatment Evaluation Units$300,000
N01 · FY2014 · AI · contact PI
Vaccine and Treatment Evaluation Units$290,933
N01 · FY2014 · AI · contact PI
Training a new generation of vaccinologists$269,165
T32 · FY2014 · AI · contact PI
VACCINE AND EVALUTION TREATMENT UNITS$230,381
N01 · FY2014 · AI · contact PI
VACCINE AND EVALUTION TREATMENT UNITS$1,225,886
N01 · FY2013 · AI · contact PI
Clinical and Statistical$949,444
U19 · FY2013 · AI · contact PI
Vaccine and Treatment Evaluation Units$540,544
N01 · FY2013 · AI · contact PI
VACCINE AND EVALUTION TREATMENT UNITS$475,886
N01 · FY2013 · AI · contact PI
VACCINE AND EVALUTION TREATMENT UNITS$426,364
N01 · FY2013 · AI · contact PI
Clinical and Statistical$325,119
U19 · FY2013 · AI · contact PI
Training a New Generation of Vaccinologists$313,499
T32 · FY2013 · AI · contact PI
Vaccine and Treatment Evaluation Units$300,000
N01 · FY2013 · AI · contact PI
VACCINE AND EVALUTION TREATMENT UNITS$50,000
N01 · FY2013 · AI · contact PI
VACCINE AND EVALUTION TREATMENT UNITS$50,000
N01 · FY2013 · AI · contact PI
VACCINE AND EVALUTION TREATMENT UNITS$1,100,000
N01 · FY2012 · AI · contact PI
Clinical and Statistical$700,313
U19 · FY2012 · AI · contact PI
Vaccine and Treatment Evaluation Units$629,614
N01 · FY2012 · AI · contact PI
VACCINE AND EVALUTION TREATMENT UNITS$600,000
N01 · FY2012 · AI · contact PI
VACCINE AND EVALUTION TREATMENT UNITS$500,000
N01 · FY2012 · AI · contact PI
VACCINE AND EVALUTION TREATMENT UNITS$500,000
N01 · FY2012 · AI · contact PI
VACCINE AND EVALUTION TREATMENT UNITS$500,000
N01 · FY2012 · AI · contact PI
VACCINE AND EVALUTION TREATMENT UNITS$500,000
N01 · FY2012 · AI · contact PI
Clinical and Statistical$346,418
U19 · FY2012 · AI · contact PI
Vaccine and Treatment Evaluation Units$300,000
N01 · FY2012 · AI · contact PI
Training a New Generation of Vaccinologists$272,667
T32 · FY2012 · AI · contact PI
VACCINE AND EVALUTION TREATMENT UNITS$256,667
N01 · FY2012 · AI · contact PI
VACCINE AND EVALUTION TREATMENT UNITS$50,000
N01 · FY2012 · AI · contact PI
VACCINE AND EVALUTION TREATMENT UNITS$1,000,000
N01 · FY2011 · AI · contact PI
VACCINE AND EVALUTION TREATMENT UNITS$1,000,000
N01 · FY2011 · AI · contact PI
VACCINE AND EVALUTION TREATMENT UNITS$1,000,000
N01 · FY2011 · AI · contact PI
Clinical and Statistical$861,009
U19 · FY2011 · AI · contact PI
VACCINE AND EVALUTION TREATMENT UNITS$600,000
N01 · FY2011 · AI · contact PI
VACCINE AND EVALUTION TREATMENT UNITS$500,000
N01 · FY2011 · AI · contact PI
Vaccine and Treatment Evaluation Units$500,000
N01 · FY2011 · AI · contact PI
Clinical and Statistical$327,593
U19 · FY2011 · AI · contact PI
Vaccine and Treatment Evaluation Units$300,000
N01 · FY2011 · AI · contact PI
Training a New Generation of Vaccinologists$251,279
T32 · FY2011 · AI · contact PI
VACCINE AND EVALUTION TREATMENT UNITS$250,000
N01 · FY2011 · AI · contact PI
Clinical and Statistical$346,764
U19 · FY2010 · AI · contact PI
Training a New Generation of Vaccinologists$247,313
T32 · FY2010 · AI · contact PI
Vaccine and Treatment Evaluation Units$1,000,000
N01 · FY2009 · AI · contact PI
Clinical and Statistical$336,240
U19 · FY2009 · AI · contact PI
Training a New Generation of Vaccinologists$245,330
T32 · FY2009 · AI · contact PI
CLINICAL RESEARCH CORE$321,007
U19 · FY2008 · AI · contact PI
ALABAMA/ZAMBIA HIV VACCINE CLINICAL TRIALS UNIT (HVTU)$1,261,890
U01 · FY2003 · AI
ALABAMA/ZAMBIA HIV VACCINE CLINICAL TRIALS UNIT (HVTU)$1,225,136
U01 · FY2002 · AI
ALABAMA/ZAMBIA HIV VACCINE CLINICAL TRIALS UNIT (HVTU)$1,189,451
U01 · FY2001 · AI
ALABAMA/ZAMBIA HIV VACCINE CLINICAL TRIALS UNIT (HVTU)$1,154,810
U01 · FY2000 · AI
AIDS VACCINE EVALUATION UNITS$378,543
N01 · FY2000 · AI